73 related articles for article (PubMed ID: 15218293)
1. Chemotherapy is more active against proximal than distal gastric carcinoma.
Higuchi K; Koizumi W; Tanabe S; Saigenji K; Ajani JA
Oncology; 2004; 66(4):269-74. PubMed ID: 15218293
[TBL] [Abstract][Full Text] [Related]
2. Proximal compared with distal gastric cancer: multivariate analysis of prognostic factors.
Pacelli F; Papa V; Caprino P; Sgadari A; Bossola M; Doglietto GB
Am Surg; 2001 Jul; 67(7):697-703. PubMed ID: 11450793
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological features and prognostic factors of proximal gastric carcinoma in a population with high Helicobacter pylori prevalence: a single-center, large-volume study in Korea.
Park JC; Lee YC; Kim JH; Kim YJ; Lee SK; Shin SK; Hyung WJ; Noh SH; Kim CB
Ann Surg Oncol; 2010 Mar; 17(3):829-37. PubMed ID: 19882188
[TBL] [Abstract][Full Text] [Related]
4. Optimal indications for second-line chemotherapy in advanced gastric cancer.
Hasegawa H; Fujitani K; Nakazuru S; Hirao M; Mita E; Tsujinaka T
Anticancer Drugs; 2012 Apr; 23(4):465-70. PubMed ID: 22227714
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological characteristics of patients with proximal third gastric carcinoma.
Kim DY; Joo JK; Ryu SY; Park YK; Kim YJ; Kim SK
Acta Chir Belg; 2004; 104(6):677-82. PubMed ID: 15663274
[TBL] [Abstract][Full Text] [Related]
6. Clinical profile of carcinoma stomach at a tertiary care hospital in south India.
Sambasivaiah K; Ibrarullah M; Reddy MK; Reddy PV; Wagholikar G; Jaiman S; Reddy DG; Sarma KV; Hegde GN
Trop Gastroenterol; 2004; 25(1):21-6. PubMed ID: 15303466
[TBL] [Abstract][Full Text] [Related]
7. Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type.
Adachi Y; Yasuda K; Inomata M; Sato K; Shiraishi N; Kitano S
Cancer; 2000 Oct; 89(7):1418-24. PubMed ID: 11013353
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
Lee YC; McCrystal MR; Christmas TI
N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant therapy for patients with locally advanced gastric carcinoma with etoposide, doxorubicin, and cisplatinum. Closing results after 5 years of follow-up.
Schuhmacher CP; Fink U; Becker K; Busch R; Dittler HJ; Mueller J; Siewert JR
Cancer; 2001 Mar; 91(5):918-27. PubMed ID: 11251943
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of multiple salvage chemotherapy for advanced gastric cancer: implications for clinical practice and trial design.
Moon YW; Rha SY; Jeung HC; Kim C; Hong MH; Chang H; Roh JK; Noh SH; Kim BS; Chung HC
Cancer Chemother Pharmacol; 2010 Sep; 66(4):797-805. PubMed ID: 20221831
[TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of adjuvant intraperitoneal chemotherapy effect prognosis of resectable gastric cancer.
Shi C; Yang B; Chen Q; Yang J; Fan N
Oncology; 2011; 80(5-6):289-95. PubMed ID: 21778768
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival and prognostic factors in patients with metastatic gastric cancers treated with chemotherapy in the Japan Clinical Oncology Group (JCOG) study.
Yoshida M; Ohtsu A; Boku N; Miyata Y; Shirao K; Shimada Y; Hyodo I; Koizumi W; Kurihara M; Yoshida S; Yamamoto S
Jpn J Clin Oncol; 2004 Nov; 34(11):654-9. PubMed ID: 15613554
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma.
Kim YH; Shin SW; Kim BS; Kim JH; Kim JG; Mok YJ; Kim CS; Rhyu HS; Hyun JH; Kim JS
Cancer; 1999 Jan; 85(2):295-301. PubMed ID: 10023695
[TBL] [Abstract][Full Text] [Related]
14. Proximal versus distal gastric carcinoma--what are the differences?
Piso P; Werner U; Lang H; Mirena P; Klempnauer J
Ann Surg Oncol; 2000 Aug; 7(7):520-5. PubMed ID: 10947021
[TBL] [Abstract][Full Text] [Related]
15. Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy.
Becker K; Mueller JD; Schulmacher C; Ott K; Fink U; Busch R; Böttcher K; Siewert JR; Höfler H
Cancer; 2003 Oct; 98(7):1521-30. PubMed ID: 14508841
[TBL] [Abstract][Full Text] [Related]
16. [Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent S-1-based neoadjuvant/adjuvant chemotherapy].
Sakurai Y; Kamoshida S; Furuta S; Sunagawa R; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y
Gan To Kagaku Ryoho; 2008 Jul; 35(7):1147-55. PubMed ID: 18633253
[TBL] [Abstract][Full Text] [Related]
17. Results of immunochemo-surgery for gastric carcinoma.
Kim JP; Yu HJ; Lee JH
Hepatogastroenterology; 2001; 48(41):1227-30. PubMed ID: 11677936
[TBL] [Abstract][Full Text] [Related]
18. Treatment outcomes of oxaliplatin, 5-FU, and leucovorin as salvage therapy for patients with advanced or metastatic gastric cancer: a retrospective analysis.
Seo HY; Kim DS; Choi YS; Sung HJ; Park KH; Choi IK; Kim SJ; Oh SC; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
Cancer Chemother Pharmacol; 2009 Feb; 63(3):433-9. PubMed ID: 18398608
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute.
Cho BC; Jeung HC; Choi HJ; Rha SY; Hyung WJ; Cheong JH; Noh SH; Chung HC
J Surg Oncol; 2007 May; 95(6):461-8. PubMed ID: 17192913
[TBL] [Abstract][Full Text] [Related]
20. Proximal gastric cancers resected via a transabdominal-only approach. Results and comparisons to distal adenocarcinoma of the stomach.
Harrison LE; Karpeh MS; Brennan MF
Ann Surg; 1997 Jun; 225(6):678-83; discussion 683-5. PubMed ID: 9230808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
